Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | DHFR | P00374 | 5/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4753235 | 0.89 | KMT2A (0.52) | DHFRKMT2A | |
| SCHEMBL4753856 | 0.88 | DHFR (0.48) | MAPTDHFRKMT2AALDH1A1 | |
| SCHEMBL4755645 | 0.88 | DHFR (0.53) | MAPTDHFR | |
| SCHEMBL4755401 | 0.85 | DHFR (0.52) | MAPTDHFR | |
| SCHEMBL4756506 | 0.85 | DHFR (0.50) | DHFRKMT2A | |
| SCHEMBL29010947 | 0.83 | DHFR (0.59) | DHFR | |
| SCHEMBL4753155 | 0.82 | DHFR (0.48) | DHFR | |
| SCHEMBL4753175 | 0.81 | DHFR (0.46) | DHFR | |
| SCHEMBL4755224 | 0.81 | DHFR (0.52) | DHFRKMT2A | |
| SCHEMBL6745912 | 0.80 | DHFR (0.59) | DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008152142-A1 | 2 -AMINOQUINAZOLINE DERIVATIVES AND THEIR THERAPEUTIC USES | SOFTCURE PHARMACEUTICALS AB (SE) | 2008-12-18 | — | — | WO | claimed |
| WO-2008152142-A1 | 2 -AMINOQUINAZOLINE DERIVATIVES AND THEIR THERAPEUTIC USES | SOFTCURE PHARMACEUTICALS AB (SE) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008152142-A1 | 2 -AMINOQUINAZOLINE DERIVATIVES AND THEIR THERAPEUTIC USES | SOFTCURE PHARMACEUTICALS AB (SE) | 2008-12-18 | — | — | WO | disclosed |